Literature DB >> 32964440

Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma.

Huaijun Chen1, Chaoran Xu1, Qian Yu1, Chen Zhong1, Yucong Peng1, Jingyin Chen1, Gao Chen1.   

Abstract

Glioblastoma (GBM) is the most common, malignant, and deadly primary glioma. Six-transmembrane epithelial antigen of prostate (STEAP) family is involved in tumorigenesis; here, we have explored the biological function and the prognostic value of the STEAP family in GBM. Differentially expressed STEAP genes in tumor and normal samples were screened by using The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression identified the prognosis-related genes: STEAP2 and STEAP3, which were involved in the regulation of immune response and cell cycle. Finally, a prognostic nomogram combining age, gender, chemotherapy, radiotherapy, IDH1 status, and the risk score model based on STEAP2 and STEAP3 was built and further validated in TCGA and Chinese Glioma Genome Atlas (CGGA) cohorts via concordance index and calibration plot, which suggested a favorable value for prognosis prediction. In conclusion, our results provided a comprehensive analysis of the STEAP family and a model for the prognosis prediction of GBM.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Gene Ontology; STEAP proteins; glioblastoma; immunomodulation; prognosis

Year:  2020        PMID: 32964440     DOI: 10.1002/jcp.30060

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

Review 1.  Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment.

Authors:  Izadora de Souza; Maria Carolina Clares Ramalho; Camila Banca Guedes; Isabeli Yumi Araújo Osawa; Linda Karolynne Seregni Monteiro; Luciana Rodrigues Gomes; Clarissa Ribeiro Reily Rocha
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

2.  A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia.

Authors:  Han Gong; Heng Li; Qin Yang; Guangxiong Zhang; Hong Liu; Zekang Ma; Hongling Peng; Ling Nie; Xiaojuan Xiao; Jing Liu
Journal:  Biomed Res Int       Date:  2022-07-06       Impact factor: 3.246

3.  Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme.

Authors:  Xudong Zhang; Shengnan Jin; Xin Shi; Shengyu Liu; Kunhang Li; Guojun Liu; Shiyu Zhong; Tao Liu; Lishuai Li; Shanwei Tao; Qingqing Zhai; Nan Bao; Lijie Ren; Ying Wu; Yijun Bao
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

4.  A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma.

Authors:  Xiangpan Li; Kewei Xiong; Dong Bi; Chen Zhao
Journal:  Front Genet       Date:  2022-04-25       Impact factor: 4.772

5.  Identifying the Predictive Role of Oxidative Stress Genes in the Prognosis of Glioma Patients.

Authors:  Di Lu; Ning Yang; Shuai Wang; Wenyu Liu; Di Zhang; Jian Wang; Bin Huang; Xingang Li
Journal:  Med Sci Monit       Date:  2021-11-27

Review 6.  Ferroptosis Involvement in Glioblastoma Treatment.

Authors:  Andrei-Otto Mitre; Alexandru Ioan Florian; Andrei Buruiana; Armand Boer; Ioana Moldovan; Olga Soritau; Stefan Ioan Florian; Sergiu Susman
Journal:  Medicina (Kaunas)       Date:  2022-02-20       Impact factor: 2.430

7.  Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer.

Authors:  Tianshu Liu; Xiaoxin Niu; Yanqing Li; Zekun Xu; Jie Chen; Geng Xu
Journal:  World J Surg Oncol       Date:  2022-03-28       Impact factor: 2.754

8.  METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.

Authors:  Yue Zhu; Xinzhi Peng; Qianlei Zhou; Langping Tan; Cheng Zhang; Shaojian Lin; Miaoyun Long
Journal:  Cell Death Dis       Date:  2022-04-18       Impact factor: 9.685

Review 9.  STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer.

Authors:  Michael Xu; Latese Evans; Candice L Bizzaro; Fabio Quaglia; Cecilia E Verrillo; Li Li; Julia Stieglmaier; Matthew J Schiewer; Lucia R Languino; William K Kelly
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

10.  DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma.

Authors:  Yingyun Guo; Yuan Li; Jiao Li; Weiping Tao; Weiguo Dong
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.